Skip to main content

Advertisement

Log in

The Evolutionary Role of the IL-33/ST2 System in Host Immune Defence

  • Review
  • Published:
Archivum Immunologiae et Therapiae Experimentalis Aims and scope

Abstract

Interleukin (IL)-33 is a recently identified pleiotropic cytokine, which can orchestrate complex innate and adaptive immune responses in immunity and disease. It has been characterized as a cytokine of the IL-1 family and affects a wide range of immune cells by signalling through its receptor ST2L. Accumulating evidence suggests a crucial role of IL-33/ST2 in inducing and modifying host immune responses against a variety of pathogens including parasites, bacteria, viruses and fungi as well as sterile insults of both endogenous and exogenous source. In this review, we endeavour to give a comprehensive overview of the current knowledge about the role of IL-33 and its receptor ST2 in host defence against infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Albonico M, Savioli L (1997) Hookworm infection and disease: advances for control. Ann Ist Super Sanita 33:567–579

    PubMed  CAS  Google Scholar 

  • Ali S, Mohs A, Thomas M et al (2011) The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol 187:1609–1616

    Article  PubMed  CAS  Google Scholar 

  • Allakhverdi Z, Smith DE, Comeau MR et al (2007) Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051–2054

    PubMed  CAS  Google Scholar 

  • Alves-Filho JC, Sonego F, Souto FO et al (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16:708–712

    Article  PubMed  CAS  Google Scholar 

  • Antignano F, Mullaly SC, Burrows K et al (2011) Trichuris muris infection: a model of type 2 immunity and inflammation in the gut. J Vis Exp pii: 2774

  • Baekkevold ES, Roussigne M, Yamanaka T et al (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163:69–79

    Article  PubMed  CAS  Google Scholar 

  • Becerra A, Warke RV, de Bosch N et al (2008) Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 41:114–120

    Article  PubMed  CAS  Google Scholar 

  • Besnard AG, Togbe D, Guillou N et al (2011) IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 41:1675–1686

    Article  PubMed  CAS  Google Scholar 

  • Bonilla WV, Frohlich A, Senn K et al (2012) The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science 335:984–989

    Article  PubMed  CAS  Google Scholar 

  • Bourgeois E, Van LP, Samson M et al (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 39:1046–1055

    Article  PubMed  CAS  Google Scholar 

  • Brough D, Le Feuvre RA, Iwakura Y et al (2002) Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol Cell Neurosci 19:272–280

    Article  PubMed  CAS  Google Scholar 

  • Carriere V, Roussel L, Ortega N et al (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 104:282–287

    Article  PubMed  CAS  Google Scholar 

  • Cayrol C, Girard JP (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 106:9021–9026

    Article  PubMed  CAS  Google Scholar 

  • Chang YJ, Kim HY, Albacker et al (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12:631–638

    Article  PubMed  CAS  Google Scholar 

  • Chaturvedi U, Nagar R, Shrivastava R (2006) Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47:155–166

    Article  PubMed  CAS  Google Scholar 

  • Enoksson M, Lyberg K, Moller-Westerberg C et al (2011) Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 186:2523–2528

    Article  PubMed  CAS  Google Scholar 

  • Espinassous Q, Garcia-de-Paco E, Garcia-Verdugo I et al (2009) IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J Immunol 183:1446–1455

    Article  PubMed  CAS  Google Scholar 

  • Gillibert-Duplantier J, Duthey B, Sisirak V et al (2012) Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. Oncogene 31:3516–3524

    Article  PubMed  CAS  Google Scholar 

  • Guo L, Wei G, Zhu J et al (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci USA 106:13463–13468

    Article  PubMed  CAS  Google Scholar 

  • Hansen JD, Vojtech LN, Laing KJ (2011) Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol 35:886–897

    Article  PubMed  CAS  Google Scholar 

  • Haraldsen G, Balogh J, Pollheimer J et al (2009) Interleukin-33—cytokine of dual function or novel alarmin? Trends Immunol 30:227–233

    Article  PubMed  CAS  Google Scholar 

  • Hayakawa H, Hayakawa M, Kume A et al (2007) Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282:26369–26380

    Article  PubMed  CAS  Google Scholar 

  • Hazlett LD, McClellan SA, Barrett RP et al (2010) IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 51:1524–1532

    Article  PubMed  Google Scholar 

  • Houghton-Trivino N, Salgado DM, Rodriguez JA et al (2010) Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation. J Gen Virol 91(Pt 3):697–706

    Article  PubMed  CAS  Google Scholar 

  • Hudson CA, Christophi GP, Gruber RC et al (2008) Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84:631–643

    Article  PubMed  CAS  Google Scholar 

  • Huising MO, Stet RJ, Savelkoul HF et al (2004) The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev Comp Immunol 28:395–413

    Article  PubMed  CAS  Google Scholar 

  • Humphreys NE, Xu D, Hepworth MR et al (2008) IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 180:2443–2449

    PubMed  CAS  Google Scholar 

  • Jones LA, Roberts F, Nickdel MB et al (2010) IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol 40:426–436

    Article  PubMed  CAS  Google Scholar 

  • Kakkar R, Hei H, Dobner S et al (2012) Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 287:6941–6948

    Article  PubMed  CAS  Google Scholar 

  • Keller M, Ruegg A, Werner S et al (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818–831

    Article  PubMed  CAS  Google Scholar 

  • Klune JR, Dhupar R, Cardinal J et al (2008) HMGB1: endogenous danger signaling. Mol Med 14:476–484

    Article  PubMed  CAS  Google Scholar 

  • Komai-Koma M, Xu D, Li Y et al (2007) IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37:2779–2786

    Article  PubMed  CAS  Google Scholar 

  • Komai-Koma M, Gilchrist DS, McKenzie AN et al (2011) IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol 186:2584–2591

    Article  PubMed  CAS  Google Scholar 

  • Kouzaki H, Iijima K, Kobayashi T et al (2011) The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 186:4375–4387

    Article  PubMed  CAS  Google Scholar 

  • Kropf P, Bickle Q, Herath S et al (2002) Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection. Eur J Immunol 32:2450–2459

    Article  PubMed  CAS  Google Scholar 

  • Kropf P, Herath S, Klemenz R et al (2003) Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection. Infect Immun 71:1961–1971

    Article  PubMed  CAS  Google Scholar 

  • Kurowska-Stolarska M, Stolarski B, Kewin P et al (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183:6469–6477

    Article  PubMed  CAS  Google Scholar 

  • Le Goffic R, Arshad MI, Rauch M et al (2011) Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol 45:1125–1132

    Article  PubMed  Google Scholar 

  • Le HT, Tran VG, Kim W et al (2012) IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals. J Immunol 189:287–295

    Article  PubMed  CAS  Google Scholar 

  • Lefrancais E, Roga S, Gautier V et al (2012) IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 109:1673–1678

    Article  PubMed  CAS  Google Scholar 

  • Liew FY (2012) IL-33: a Janus cytokine. Ann Rheum Dis 71(Suppl 2):i101–i104

    Article  PubMed  CAS  Google Scholar 

  • Liew FY, Pitman NI, McInnes IB (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10:103–110

    Article  PubMed  CAS  Google Scholar 

  • Lohning M, Stroehmann A, Coyle AJ et al (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95:6930–6935

    Article  PubMed  CAS  Google Scholar 

  • Luthi AU, Cullen SP, McNeela EA et al (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84–98

    Article  PubMed  CAS  Google Scholar 

  • Medzhitov R, Schneider DS, Soares MP (2012) Disease tolerance as a defense strategy. Science 335:936–941

    Article  PubMed  CAS  Google Scholar 

  • Monticelli LA, Sonnenberg GF, Abt MC et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045–1054

    Article  PubMed  CAS  Google Scholar 

  • Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS One 3:e3331

    Article  PubMed  Google Scholar 

  • Nagata A, Takezako N, Tamemoto H et al (2012) Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells. Cell Mol Immunol 9:399–409

    Article  PubMed  CAS  Google Scholar 

  • Neill DR, Wong SH, Bellosi A et al (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367–1370

    Article  PubMed  CAS  Google Scholar 

  • Nelson MP, Christmann BS, Werner JL et al (2011) IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 186:2372–2381

    Article  PubMed  CAS  Google Scholar 

  • Nile CJ, Barksby E, Jitprasertwong P et al (2010) Expression and regulation of interleukin-33 in human monocytes. Immunology 130:172–180

    Article  PubMed  Google Scholar 

  • Oboki K, Ohno T, Kajiwara N et al (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 107:18581–18586

    Article  PubMed  CAS  Google Scholar 

  • Onda H, Kasuya H, Takakura K et al (1999) Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19:1279–1288

    Article  PubMed  CAS  Google Scholar 

  • Paul WE, Zhu J (2010) How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10:225–235

    Article  PubMed  CAS  Google Scholar 

  • Pecaric-Petkovic T, Didichenko SA, Kaempfer S et al (2009) Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113:1526–1534

    Article  PubMed  CAS  Google Scholar 

  • Peiris JS, Cheung CY, Leung CY et al (2009) Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol 30:574–584

    Article  PubMed  CAS  Google Scholar 

  • Pichery M, Mirey E, Mercier P et al (2012) Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 188:3488–3495

    Article  PubMed  CAS  Google Scholar 

  • Polumuri SK, Jayakar GG, Shirey KA et al (2012) Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J Immunol 189:50–60

    Article  PubMed  CAS  Google Scholar 

  • Price AE, Liang HE, Sullivan BM et al (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107:11489–11494

    Article  PubMed  CAS  Google Scholar 

  • Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264–296

    Article  PubMed  CAS  Google Scholar 

  • Schlenke TA, Begun DJ (2003) Natural selection drives Drosophila immune system evolution. Genetics 164:1471–1480

    PubMed  CAS  Google Scholar 

  • Schmitz J, Owyang A, Oldham E et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490

    Article  PubMed  CAS  Google Scholar 

  • Shimosato T, Fujimoto M, Tohno M et al (2010) CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9. Biochem Biophys Res Commun 394:81–86

    Article  PubMed  CAS  Google Scholar 

  • Smith DE (2010) IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 40:200–208

    Article  PubMed  CAS  Google Scholar 

  • Smithgall MD, Comeau MR, Yoon BR et al (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20:1019–1030

    Article  PubMed  CAS  Google Scholar 

  • Spits H, Cupedo T (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30:647–675

    Article  PubMed  CAS  Google Scholar 

  • Stein C, Caccamo M, Laird G et al (2007) Conservation and divergence of gene families encoding components of innate immune response systems in zebrafish. Genome Biol 8:R251

    Article  PubMed  Google Scholar 

  • Suzukawa M, Iikura M, Koketsu R et al (2008) An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 181:5981–5989

    PubMed  CAS  Google Scholar 

  • Takezako N, Hayakawa M, Hayakawa H et al (2006) ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun 341:425–432

    Article  PubMed  CAS  Google Scholar 

  • Tominaga S, Jenkins NA, Gilbert DJ et al (1991) Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping. Biochim Biophys Acta 1090:1–8

    Article  PubMed  CAS  Google Scholar 

  • Wagenaar JF, Gasem MH, Goris MG et al (2009) Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis 3:e453

    Article  PubMed  Google Scholar 

  • Wieland CW, van der Windt GJ, Florquin S et al (2009) ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis. Microbes Infect 11:524–530

    Article  PubMed  CAS  Google Scholar 

  • Wilhelm C, Stockinger B (2011) Innate lymphoid cells and type 2 (th2) mediated immune responses—pathogenic or beneficial? Front Immunol 2:68

    Article  PubMed  Google Scholar 

  • Xu D, Chan WL, Leung BP et al (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187:787–794

    Article  PubMed  CAS  Google Scholar 

  • Xu D, Jiang HR, Kewin P et al (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 105:10913–10918

    Article  PubMed  CAS  Google Scholar 

  • Yanagisawa K, Takagi T, Tsukamoto T et al (1993) Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 318:83–87

    Article  PubMed  CAS  Google Scholar 

  • Yang Q, Li G, Zhu Y et al (2011) IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol 41:3351–3360

    Article  PubMed  CAS  Google Scholar 

  • Yasuda K, Muto T, Kawagoe T et al (2012) Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci USA 109:3451–3456

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Lu R, Zhao G et al (2011) TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. Int J Biochem Cell Biol 43:1383–1391

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanne Sattler.

About this article

Cite this article

Sattler, S., Smits, H.H., Xu, D. et al. The Evolutionary Role of the IL-33/ST2 System in Host Immune Defence. Arch. Immunol. Ther. Exp. 61, 107–117 (2013). https://doi.org/10.1007/s00005-012-0208-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00005-012-0208-8

Keywords

Navigation